Concepts (138)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammatory Bowel Diseases | 5 | 2021 | 2442 | 0.380 |
Why?
|
| Self Care | 1 | 2016 | 797 | 0.370 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 873 | 0.360 |
Why?
|
| Pancreatitis | 1 | 2016 | 1087 | 0.330 |
Why?
|
| Mesoderm | 1 | 2010 | 679 | 0.270 |
Why?
|
| Dyspepsia | 1 | 2006 | 116 | 0.250 |
Why?
|
| Medication Adherence | 1 | 2016 | 2189 | 0.240 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2016 | 4047 | 0.190 |
Why?
|
| Epithelial Cells | 2 | 2010 | 3695 | 0.190 |
Why?
|
| Intestines | 1 | 2010 | 1912 | 0.180 |
Why?
|
| Myositis | 1 | 2003 | 276 | 0.180 |
Why?
|
| Career Choice | 1 | 2017 | 769 | 0.170 |
Why?
|
| Gastroenterology | 1 | 2017 | 589 | 0.170 |
Why?
|
| Abscess | 1 | 2003 | 606 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2010 | 4177 | 0.160 |
Why?
|
| Teaching | 1 | 2017 | 1172 | 0.160 |
Why?
|
| Growth Substances | 1 | 2001 | 761 | 0.160 |
Why?
|
| Fructose Intolerance | 1 | 2017 | 8 | 0.150 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1133 | 0.150 |
Why?
|
| Islets of Langerhans | 2 | 2001 | 1350 | 0.150 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2017 | 1082 | 0.140 |
Why?
|
| Colonoscopy | 2 | 2023 | 1412 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2023 | 1126 | 0.130 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2001 | 748 | 0.130 |
Why?
|
| Fructose | 1 | 2017 | 284 | 0.130 |
Why?
|
| Drug Monitoring | 1 | 2021 | 964 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2003 | 1398 | 0.120 |
Why?
|
| Education, Medical, Graduate | 1 | 2017 | 2412 | 0.120 |
Why?
|
| Israel | 1 | 2016 | 726 | 0.110 |
Why?
|
| Intestinal Mucosa | 2 | 2017 | 3048 | 0.110 |
Why?
|
| Colitis | 2 | 2013 | 1244 | 0.100 |
Why?
|
| Hypothalamic Hormones | 1 | 2013 | 145 | 0.100 |
Why?
|
| Pituitary Hormones | 1 | 2013 | 182 | 0.100 |
Why?
|
| Colonic Diseases | 1 | 2013 | 203 | 0.090 |
Why?
|
| Melanins | 1 | 2013 | 289 | 0.090 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2010 | 65 | 0.090 |
Why?
|
| Patient Admission | 1 | 2018 | 1367 | 0.090 |
Why?
|
| Lac Operon | 1 | 2010 | 237 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2010 | 110 | 0.090 |
Why?
|
| Pancreas | 1 | 2016 | 1702 | 0.080 |
Why?
|
| Colonic Polyps | 1 | 2014 | 557 | 0.080 |
Why?
|
| Fibrosis | 3 | 2013 | 2077 | 0.080 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 575 | 0.080 |
Why?
|
| Kidney Tubules | 1 | 2010 | 448 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2001 | 3981 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2023 | 4748 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2010 | 637 | 0.070 |
Why?
|
| Acute Disease | 1 | 2016 | 7242 | 0.060 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2010 | 755 | 0.060 |
Why?
|
| Cadherins | 1 | 2010 | 906 | 0.060 |
Why?
|
| Adenoma | 1 | 2014 | 2163 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 5800 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1658 | 0.050 |
Why?
|
| Male | 11 | 2023 | 364902 | 0.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2001 | 558 | 0.050 |
Why?
|
| Liver | 1 | 2017 | 7574 | 0.050 |
Why?
|
| Colon | 1 | 2010 | 1805 | 0.050 |
Why?
|
| Subrenal Capsule Assay | 1 | 2001 | 27 | 0.050 |
Why?
|
| Phosphoproteins | 2 | 2001 | 2448 | 0.050 |
Why?
|
| Cell Line | 3 | 2013 | 15597 | 0.050 |
Why?
|
| Workload | 1 | 2017 | 852 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2001 | 418 | 0.040 |
Why?
|
| Proteins | 2 | 2010 | 6006 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2103 | 0.040 |
Why?
|
| Female | 9 | 2023 | 397089 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4357 | 0.040 |
Why?
|
| Glucose Transporter Type 5 | 1 | 2017 | 13 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7955 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2017 | 12166 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 57 | 0.040 |
Why?
|
| Drainage | 1 | 2003 | 1184 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9562 | 0.040 |
Why?
|
| Middle Aged | 5 | 2023 | 223491 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2001 | 838 | 0.040 |
Why?
|
| Humans | 11 | 2023 | 768393 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2006 | 2660 | 0.030 |
Why?
|
| Lipogenesis | 1 | 2017 | 216 | 0.030 |
Why?
|
| Mice, Knockout | 3 | 2017 | 14481 | 0.030 |
Why?
|
| Adolescent | 3 | 2018 | 89184 | 0.030 |
Why?
|
| Leptin | 2 | 2001 | 1597 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 1429 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2010 | 4300 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 1997 | 261 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 325 | 0.030 |
Why?
|
| Time Factors | 3 | 2023 | 40272 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 6971 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 3 | 2010 | 22355 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19022 | 0.030 |
Why?
|
| Mice | 5 | 2013 | 82017 | 0.030 |
Why?
|
| Curriculum | 1 | 2017 | 3776 | 0.030 |
Why?
|
| Body Weight | 2 | 2001 | 4629 | 0.030 |
Why?
|
| Animals | 7 | 2017 | 169337 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2001 | 1389 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2013 | 138 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2021 | 2126 | 0.020 |
Why?
|
| Myofibroblasts | 1 | 2013 | 229 | 0.020 |
Why?
|
| Adult | 4 | 2023 | 223640 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2017 | 2940 | 0.020 |
Why?
|
| Insulin | 2 | 2001 | 6607 | 0.020 |
Why?
|
| Cholesterol | 1 | 2017 | 2912 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 6510 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2001 | 6430 | 0.020 |
Why?
|
| Disease Progression | 1 | 2003 | 13646 | 0.020 |
Why?
|
| Weight Loss | 1 | 2017 | 2713 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2018 | 1929 | 0.020 |
Why?
|
| Actins | 1 | 2013 | 2059 | 0.020 |
Why?
|
| Atrophy | 1 | 2010 | 1648 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2018 | 2293 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2013 | 1943 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2013 | 2003 | 0.020 |
Why?
|
| Collagen | 1 | 2013 | 2646 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2013 | 4142 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 8075 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2010 | 4834 | 0.010 |
Why?
|
| Wound Healing | 1 | 2013 | 2813 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12778 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2010 | 1802 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 20765 | 0.010 |
Why?
|
| Obesity | 1 | 2001 | 13084 | 0.010 |
Why?
|
| Aged | 2 | 2023 | 171562 | 0.010 |
Why?
|
| Hospitalization | 1 | 2018 | 10844 | 0.010 |
Why?
|
| Glucagon | 1 | 1999 | 534 | 0.010 |
Why?
|
| Estrus | 1 | 1997 | 70 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10478 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 36510 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1997 | 436 | 0.010 |
Why?
|
| Growth | 1 | 1997 | 366 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 42650 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2023 | 81801 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 59686 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4588 | 0.010 |
Why?
|
| Vagina | 1 | 1997 | 845 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 60049 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 30022 | 0.010 |
Why?
|
| United States | 1 | 2018 | 73150 | 0.010 |
Why?
|
| Estradiol | 1 | 1997 | 1952 | 0.010 |
Why?
|
| Child | 1 | 2018 | 80891 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1997 | 23631 | 0.000 |
Why?
|
Concepts
(138)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_